Glunz & Jensen A/S
To Nasdaq OMX Copenhagen A/S
Public announcement no. 489
March 10th, 2021
RELATED PARTY TRANSACTION
Glunz & Jensen Holding A/S announces that the company today has received pursuant to section 38 of the Capital Market Act and section 55 of the Danish Companies Act, where Flemming Nyenstad Enevoldsen notifies Glunz & Jensen Holding A/S ("Glunz & Jensen ") that Flemming Nyenstad Enevoldsen has increased his shareholding in Glunz & Jensen by purchasing 863 shares in Glunz & Jensen at nominal DKK 20.
After the purchase, Flemming Nyenstad Enevoldsen owns a total of 4.170 shares, corresponding to 0,23% of the total share capital and voting rights in Glunz & Jensen.
See attached information for further details.
For further information please contact:
CEO Martin Overgaard Hansen: phone +45 22 60 84 05
Chairman of the board Flemming Nyenstad Enevoldsen: phone +45 40 43 13 03
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
ALK Abello19.12.2025 22:46:46 CET | Press release
Major shareholder announcement
ALK Abello19.12.2025 22:46:46 CET | Pressemeddelelse
Storaktionærmeddelelse
Zealand Pharma19.12.2025 22:00:00 CET | Press release
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Boehringer Ingelheim Limited19.12.2025 21:10:00 CET | Press release
U.S. FDA approves JASCAYD® (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults
Novartis Pharma AG19.12.2025 20:30:06 CET | Press release
Novartis and US government reach agreement on lowering drug prices in the US
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
